All Stories

  1. Tetanus Surveillance — United States, 2009–2023
  2. Mortality Among Youth and Young Adults With Autism Spectrum Disorder, Intellectual Disability, or Cerebral Palsy
  3. Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2024
  4. Social vulnerability and the prevalence of autism spectrum disorder among 8-year-old children, Autism and Developmental Disabilities Monitoring Network, 2020
  5. Fever Among Pertussis Cases Reported Through Enhanced Pertussis Surveillance, 2015–2022
  6. Regional differences in autism and intellectual disability risk associated with cesarean section delivery
  7. National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2023
  8. Health Conditions, Education Services, and Transition Planning for Adolescents With Autism
  9. Response to Letter to the Editor: “‘Profound Autism’ Label Does Not Predict Strengths or Help Plan Supports”
  10. Adolescents With Autism Spectrum Disorder: Diagnostic Patterns, Co-occurring Conditions, and Transition Planning
  11. Social vulnerability and prevalence of Autism Spectrum Disorder, Metropolitan Atlanta Developmental Disabilities Surveillance Program (MADDSP)
  12. Individualized Education Programs and Transition Planning for Adolescents With Autism
  13. The Prevalence and Characteristics of Children With Profound Autism, 15 Sites, United States, 2000-2016
  14. Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020
  15. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020
  16. Statewide county-level autism spectrum disorder prevalence estimates—seven U.S. states, 2018
  17. Progress and Disparities in Early Identification of Autism Spectrum Disorder: Autism and Developmental Disabilities Monitoring Network, 2002-2016
  18. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
  19. Sensory features in autism: Findings from a large population‐based surveillance system
  20. Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018
  21. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018
  22. County-Level COVID-19 Vaccination Coverage and Social Vulnerability — United States, December 14, 2020–March 1, 2021
  23. Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program — United States, December 14, 2020–January 14, 2021
  24. Update: Characteristics of Health Care Personnel with COVID-19 — United States, February 12–July 16, 2020
  25. Support for Transition from Adolescent to Adult Health Care Among Adolescents With and Without Mental, Behavioral, and Developmental Disorders — United States, 2016–2017
  26. Geographic Differences in COVID-19 Cases, Deaths, and Incidence — United States, February 12–April 7, 2020
  27. Characteristics of Health Care Personnel with COVID-19 — United States, February 12–April 9, 2020
  28. Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020
  29. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
  30. A Community-Driven Probability Survey of Disadvantaged Populations in Chicago: Sinai Community Health Survey 2.0
  31. Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019
  32. Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, October 2019
  33. Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden in the United States
  34. Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection
  35. Effect of acute respiratory illness on short‐term frailty status of older adults in Nakhon Phanom, Thailand—June 2015 to June 2016: A prospective matched cohort study
  36. Notes from the Field: Assessment of State-Level Influenza Season Severity — Minnesota and Utah, 2017–18 Influenza Season
  37. Local Disparities in Breastfeeding Initiation and Duration: A Cross-Sectional Population-Based Survey in Ten Chicago Community Areas
  38. Local-Level Adult Influenza and Pneumococcal Vaccination Disparities: Chicago, Illinois, 2015–2016
  39. Pertussis seroepidemiology in women and their infants in Sarlahi District, Nepal
  40. Population-Based Pertussis Incidence and Risk Factors in Infants Less Than 6 Months in Nepal
  41. Racial Disparities in Heart Disease Mortality in the 50 Largest U.S. Cities
  42. Racial Disparities in Prostate Cancer Mortality in the 50 Largest US Cities
  43. 2500-g Low Birth Weight Cutoff: History and Implications for Future Research and Policy
  44. Community-Based Diabetes Community Health Worker Intervention in an Underserved Chicago Population
  45. Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal
  46. Seasonality of birth outcomes in rural Sarlahi District, Nepal: a population-based prospective cohort
  47. Association of vaccine-related attitudes and beliefs between parents and health care providers
  48. Are Recent Medical Graduates More Skeptical of Vaccines?
  49. Immunization-Safety Monitoring Systems for the 2009 H1N1 Monovalent Influenza Vaccination Program